Learn more about whether Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's ...

Learn more about whether Ionis Pharmaceuticals, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Several different processes -- congenital and acquired -- may result in the development of short bowel syndrome ... well as catastrophic vascular events (mesenteric vein or arterial thrombosis ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) stock has touched a 52-week low, dipping to $31.24, as investors respond to a ...

Schwachman Diamond Syndrome, Progressive Muscular Atrophy ... Some rare diseases such as ‘butterfly skin or EB’, ‘Spinal muscular atrophy (SMA)’, ‘Metabolic diseases’, ‘Autism’, and ‘Dystrophies’ are ...

The health activists argue that the government is empowered with effective law and policy tools and therefore should ...

For 6 years, a college cross-country skier experiened pain that kept her from school and skiing. Finally, she was diagnosed ...

Since its launch on 2 January, Sebaashray has redefined healthcare accessibility in Diamond Harbour, touching the lives of ...

SG Americas Securities LLC boosted its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 222.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 23,927 shares ...

“HELLP syndrome was not mentioned as a complication in former studies of SMA patients, and can be seen as a coincidence in this patient,” the scientists noted. Her newborn daughter appeared normal in ...